Kiniksa Pharmaceuticals International, plc
Assets & Liabilities
| Period | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| Mar 2022 | $64.7M | $231.0M | $63.3M |
| Jun 2022 | $57.1M | $210.6M | $94.3M |
| Sep 2022 | $75.9M | $460.0M | $175.8M |
| Dec 2022 | $63.5M | $459.7M | $122.7M |
| Mar 2023 | $52.8M | $442.9M | $80.6M |
| Jun 2023 | $72.7M | $484.3M | $112.6M |
| Sep 2023 | $77.9M | $483.1M | $117.8M |
| Dec 2023 | $87.5M | $526.3M | $108.0M |
| Mar 2024 | $87.8M | $519.7M | $141.1M |
| Jun 2024 | $107.3M | $542.4M | $99.3M |
| Sep 2024 | $118.3M | $555.3M | $97.4M |
| Dec 2024 | $142.1M | $580.6M | $183.6M |
| Mar 2025 | $141.8M | $599.3M | $157.1M |
| Jun 2025 | $166.1M | $661.2M | $192.0M |
| Sep 2025 | $177.0M | $712.3M | $174.9M |
| Dec 2025 | $196.0M | $763.6M | $165.6M |
| Mar 2026 | $219.6M | $825.3M | $190.0M |